Doctors and Drug Companies
- 28 October 2004
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (18), 1885-1890
- https://doi.org/10.1056/nejmhpr042734
Abstract
In this article, Blumenthal describes the nature of current relationships between doctors and the pharmaceutical industry. The report analyzes how financial relationships — which may involve gifts, free meals, consulting fees, or lecture honoraria — influence physicians' prescribing decisions and how the relationships between physicians and drug companies are likely to change in the future.Keywords
This publication has 22 references indexed in Scilit:
- Health Spending Rebound Continues In 2002Health Affairs, 2004
- Interactions between Emergency Medicine Programs and the Pharmaceutical IndustryAcademic Emergency Medicine, 2004
- Quality of Health Care Delivered to Adults in the United StatesNew England Journal of Medicine, 2003
- Cost and Quality of Industry-Sponsored Meals for Medical ResidentsRESEARCH LETTERSJAMA, 2003
- All Gifts Large and SmallAmerican Journal of Bioethics, 2003
- How to dance with porcupines: rules and guidelines on doctors' relations with drug companiesBMJ, 2003
- Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: DisentanglementBMJ, 2003
- Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: EntanglementBMJ, 2003
- Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional studyBMJ, 2003
- EditorialAmerican Journal Of Medicine, 1999